CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Defines what an index value represents in finance and how investors use it to gauge market performance and relative movement.
22,151 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
A leading career expert warns that overreliance on AI could dull judgment and make skilled workers more vulnerable to...
Layoffs are being used to finance AI deployments as global AI expenditure rockets toward trillions. CEOs insist the ...
When a member of a royal family steps into the public eye after a major news cycle, personal finances can feel the pr...
Trump Mobile says the gold-plated T1 phone will ship this week after nearly year delays, with deposits collected and ...
Peter Buffett’s late discovery of his father’s billionaire status tracks a broader story about wealth, privacy, and r...
In 2026, U.S. homebuilders are turning to AI-powered ERP to uncover margin leaks and streamline project handoffs as d...
When North West stepped onto the Paris stage with electric blue hair and punk flair, she sparked more than headlines—...
Meta Platforms is dialing up AI infrastructure spending, guiding 2026 capex to $125-145 billion after a strong Q1. Th...
What happens when the urge to profit from other people’s drama collides with real-life costs? This article breaks dow...
As Iran-related conflict enters its fourth week, airlines brace for a fuel-cost shock even as travelers return and fa...
Palantir just posted its first $1B-plus quarter, pushing it into the world’s top-25 by market value and redefining th...